Our mission
Help more family have healthy babies
We expertise in the research and application of genetic technology in reproductive health. In particular, we aim to help patients struggling with infertility and those afflicted with inheritance disorders.
Being a leading brand
Suzhou BaseCare, founded in 2010, is dedicated to the research, development, and clinical application of high-throughput sequencing technology in the field of reproductive health. So far, BaseCare consists of a 1500㎡ manufacturing centre, a 3000㎡ research centre, and a 4000㎡ detection centre.
The one ideology we constantly uphold is “Quality First”. We followed strict specifications in developing, licensing, and certifying our products. Over the years, we have made some substantial progress. In 2015, we applied for our PGT-A kit to be classified as Class-III Medical Devices, and regulated by the Standardization Administration. In 2016, the PGT-A kit was granted special approval for innovative medical devices to enter the phase of clinical trial. In 2017, we participated in the formulation of QCS (quality control specification) for all PGT-A products. In 2018, we obtained the qualification of GMP workshop production. Finally, in Feb. 21 2020, our PGT-A kit won the CFDA approval, signifying the beginning of a new era in which China’s IVF technology is licensed and regulated under CFDA.
Our goal is to help more and more families using cutting-edge technologies. In doing so, we hope to contribute in the eugenic engineering of our nation, and our species. Hence, we will indefatigably march towards our BaseCare Vision.
Our Value
We make haste. We seek perfection. We try hard and give it all we have.
(BaseCare pace, BaseCare standard, BaseCare spirit)
We march forward together
From the company's start-up to the clinical application, and then to the approval of PGT-A products on the
market, the development path of the decade is full of hardships and sweat Water, but more full of passion
and hope. We thank you for all the support you generously gave us in the past decade.
The company was founded to build a big data biological information analysis platform, and began to provide scientific research services based on the next generation sequencing technology.
2010
March
The PGT-A kit officially obtained the world's first registration certificate of Class III medical devices, and the PGT-A officially entered the era of certification.
2020
March
Our clinical trial for PGT-A kit is the world’s largest clinical trial with the largest amount of data.
2019
November
Obtained the GMP workshop production qualification, has the large-scale medical equipment production capacity, lays the solid foundation for the industrialization.
2018
August
Participated in the development of PGT-A quality control evaluation guidelines, to fill the gap of China's third generation IVF quality control technical standards.
2017
October
Established productive & genetic clinical research center with Thermo fisher.
2016
September
Approval of national innovative medical devices, which raised the level of standardization of third generation IVF industry.
2015
April
Cooperated with Dana gene to complete the registration of second generation sequencer and NIP kit.
2014
May
Set up joint laboratory with Life science to develop the first NIPT detection kit based on second generation sequencer.
2013
June
The company was founded to build a big data biological information analysis platform, and began to provide scientific research services based on the next generation sequencing technology.